STOCKSCREENR

0R2M.L

LSE

Regeneron Pharmaceuticals, Inc.

$709.00+5.78(+0.82%)Mkt Cap: $76.60B

Key Stats

Market Cap

$76.60B

P/E Ratio

10.08

EPS

$70.31

Dividend Yield

0.47%

52-Week Range

$685.53 — $998.57

Volume

455

Avg Volume

1.96K

Beta

0.40

Price Alerts for 0R2M.L

Get alerted when 0R2M.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

10.08

Forward P/E

15.64

PEG Ratio

-23.43

P/S (TTM)

5.47

P/B (TTM)

2.49

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

0.15%

ROA (TTM)

0.11%

ROIC

—

Gross Margin

0.85%

Operating Margin

0.25%

Net Margin

—

Debt/Equity

0.09

Current Ratio

4.13

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.02%

EPS Growth (5Y)

+0.19%

Sales Growth (3Y)

+0.06%

Sales Growth (5Y)

+0.16%

EPS Est (This Year)

$45.34

EPS Est (Next Year)

$52.73

Dividends

Dividend Yield

—

Annual Dividend

$0.88

Payout Ratio

—

Frequency

—

Ex-Dividend Date

2025-11-20

Cash/Share

$83.63

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

-3874

Outstanding Shares

108.03M

Float

98.54M

Free Float %

91.21%

Technicals

RSI (14)

48.05

SMA 20

$779.65

SMA 50

$770.41

SMA 200

$647.81

ATR (14)

22.61

Volatility (Week)

0.02%

Volatility (Month)

0.02%

Pattern

—

Performance

1 Day

+1.42%

1 Week

+1.72%

1 Month

+0.47%

3 Months

+8.50%

6 Months

+37.94%

1 Year

—

YTD

+1.62%

All-Time High

$819.21

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

US

Exchange

LSE

IPO Date

2014-11-05

Employees

15158

CEO

Leonard S. Schleifer

Index Membership

—

Website

https://www.regeneron.com

Regeneron Pharmaceuticals, Inc. (0R2M.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $76.60B, a P/E ratio of 10.08, and a dividend yield of 0.47%, 0R2M.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0R2M.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

0QZU.L

Vertex Pharmaceuticals Incorporated

$434.30

+1.15%

$111.62B

0M3Q.L

Zoetis Inc.

$115.60

+1.72%

$55.54B

0HD2.L

Alnylam Pharmaceuticals, Inc.

$319.08

+7.54%

$42.32B

0RD1.L

Camurus AB (publ)

$530.55

+0.06%

$31.64B

0JAV.L

Insmed Incorporated

$136.55

+1.81%

$29.44B

0JDM.L

IQVIA Holdings Inc.

$158.90

+1.74%

$26.97B

Frequently Asked Questions

What is Regeneron Pharmaceuticals, Inc.'s P/E ratio?

Regeneron Pharmaceuticals, Inc. (0R2M.L) has a trailing twelve-month (TTM) P/E ratio of 10.08. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Regeneron Pharmaceuticals, Inc. pay a dividend?

No, Regeneron Pharmaceuticals, Inc. (0R2M.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Regeneron Pharmaceuticals, Inc.'s market cap?

Regeneron Pharmaceuticals, Inc. (0R2M.L) has a market capitalization of $76.60 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

How has 0R2M.L performed this year?

Regeneron Pharmaceuticals, Inc. (0R2M.L) has returned +1.62% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.